• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Healthcare

Inflexion sells Pharmaspectra to IQVIA for USD 100m

  • Rachel Lewis
  • 12 August 2022
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Private equity firm Inflexion has sold medical data disseminator Pharmaspectra to US-listed health information company IQVIA, generating a 25% IRR.

The deal was valued at USD 100m, according to a source familiar with the situation. 

The GP said it increased the company's client base by 160% over three years by investing in sales, marketing and client services. Inflexion added that it also supported market entry into China and the build-out of the team in India. 

Pharmaspectra

  • DEAL:

    Trade sale

  • VALUE:

    USD 100m

  • LOCATION:

    London

  • SECTOR:

    Business support services

  • FOUNDED:

    2005

  • VENDOR:

    Inflexion

  • RETURNS:

    25% IRR

Inflexion acquired Pharmaspectra in 2019 via Enterprise Fund IV, which has been fully deployed since the end of that year. The fund invested tickets of GBP 10m-GBP 20m.

The exit is Inflexion's fourth from that fund, following Goals Soccer Centre, Halo Technology, and Virgin Experience Days. 

Inflexion has made nine exits to date in 2022 with a combined valuation of GBP 2.5bn, it said in a statement. 

The GP closed its latest enterprise fund Fund V in May 2019 at GBP 400m. 

People 

Inflexion - Ben Long (partner), Saloshnee Nightingale (assistant director) and Andrea Johnson (investment executive).

Pharmaspectra - Jez Moulding (CEO).

Company
Pharmaspectra hosts a continuously updated and integrated online repository of disseminated medical science information. This includes 16m meeting presentations, 28m publication abstracts, and 417,000 clinical trial results. This data is used across the pharmaceutical sector in which Pharmaspectra has an expansive and diverse customer base, including 13 of the top 20 pharma companies.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Healthcare
  • Exits
  • GPs
  • Inflexion Private Equity

More on Healthcare

Final closes of private equity funds in euros
Bewater Funds nears EUR 7m close for second fund, aims to back 20 companies in next four years

Bewater II FCRE takes minority stakes (5%-25%) with tickets of EUR 500,000-EUR 2m, and it has already made three investments.

  • Funds
  • 01 June 2023
Joakim Noto of Mimir Group
Mimir Group ramps up global origination effort with London office and focus on life science carve-outs

Stockholm-based investor is considering divestments, although challenging market remains a barrier

  • Nordics
  • 26 May 2023
Microscopes and laboratory facilities
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global

Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt

  • Healthcare
  • 26 May 2023
Bolt-ons and buy-and-build platforms
The Bolt-Ons Digest - 26 May 2023

Unquote’s selection of the latest add-ons with H&F's TeamSystem, Nordic Capital's Regnology, 3'i's Dutch Bakery and more

  • Expansion
  • 26 May 2023

Latest News

2015 was a mixed bag for southern Europe and has bestowed an air of caution among its private equity practitioners looking ahead
  • Buyouts
Carlyle acquires Meopta

GP plans to support Czech-American optical products manufacturer’s international expansion

  • 02 June 2023
Bugaboo produces prams and luggage
  • Exits
Bugaboo backer Bain strolls back to market for H2 2022 launch

Sale of pram maker was initially launched last year but did not proceed due to credit market and consumer sector concerns

  • 02 June 2023
Construction consultants
  • Buyouts
Officine Maccaferri sees Cinven and Triton go head-to-head

Italy-based geotechnical and soil erosion control business could be valued at EUR 700m-EUR 800m

  • 02 June 2023
Fundraising in US dollars
  • Funds
Adams Street secures USD 3.2bn for newest secondaries programme amid LP stakes dealflow uptick

Private markets investor has seen LP stakes increase as a proportion of its deployment over the past year, partner Jeff Akers said

  • 01 June 2023
Back to Top

Most read

2015 was a mixed bag for southern Europe and has bestowed an air of caution among its private equity practitioners looking ahead
Carlyle acquires Meopta
Bugaboo produces prams and luggage
Bugaboo backer Bain strolls back to market for H2 2022 launch
Construction consultants
Officine Maccaferri sees Cinven and Triton go head-to-head
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013